Skip to main content
Assets
Medtronic logo
MDT.NYSE
Medtronic
Health Care · Health Care Equipment

Medical technology company providing devices, services, and therapies across cardiovascular, surgical, neuroscience, and diabetes care.

HQ: IrelandListed: United States

Profile & Fundamentals

Medtronic: Company identity, ownership, reported financial performance, balance sheets, and corporate actions.

Profile & Fundamentals

Medtronic Profile & Fundamentals

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables
Explore this pageJump to a Profile & Fundamentals section

Company and Market Context

Company Profile & Ownership

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys

MDT.NYSE

Company profile record

Medtronic PLC

Common Stock · Health Care · Health Care Equipment

Official website

Company

Company / asset
Medtronic PLC
Security type
Common Stock
Sector
Health Care
Industry
Health Care Equipment
HQ
🇮🇪 Ireland
Head office
Building Two, Galway, Ireland, H91 4K49

Leadership & scale

Chief executive
Mr. Geoffrey Straub Martha
CEO year born
1970
Full-time employees
95K
Fiscal year end
April
IPO date
1978-01-13

Fundamentals snapshot

Updated 2026-09-14
Market Cap
USD 118.4B
P/E
22.6x
Revenue (Q3 26)
USD 9.8B
Profit (Q3 26)
USD 1.5B
Dividend Yield
2.2%
Revenue (FY 26)
USD 36.4B
Shares in public float
1.3B
Insider ownership
0.39%

Reporting & identifiers

Symbol
MDT.NYSE
Listing
🇺🇸 United States | Dividend Tax: 30%
Ticker Currency
USD
Income Statement Currency
USD
Balance Sheet Currency
USD
Cash Flow Currency
USD
EPS Currency
USD
Contract Type
SPOT
ISIN
IE00BTN1Y115
Asset ID
equity_d573891f-97f3-5a8e-8b19-5db704eef9c9

Ownership

Shares Outstanding

Shares OutstandingAnnual reported shares outstanding. Values in shares.1.26B1.29B1.33B1.36B1.39BJan 2017Apr 2019Jul 2021Oct 2023Jan 2026
  • Shares outstanding
Annual reported shares outstanding. Values in shares.

Top holders

  1. BlackRock Inc113,182,567 shares · 8.85% · Reported 2026-03-31
  2. Vanguard Capital Management, LLC83,333,833 shares · 6.51% · Reported 2026-03-31
  3. State Street Corp61,741,014 shares · 4.83% · Reported 2026-03-31
  4. JPMorgan Chase & Co50,973,541 shares · 3.98% · Reported 2026-03-31
  5. Vanguard MStar Total Stk Mkt Idx Invest40,879,781 shares · 3.20% · Reported 2026-07-31
  6. Vanguard 500 Index Investor33,705,113 shares · 2.63% · Reported 2026-07-31
  7. Vanguard Portfolio Management, LLC33,450,558 shares · 2.62% · Reported 2026-03-31
View more holders (8)
  1. Geode Capital Management, LLC28,736,341 shares · 2.25% · Reported 2026-03-31
  2. Arnhold & S. Bleichroeder Advisers, LLC27,567,966 shares · 2.16% · Reported 2026-06-30
  3. Bank of America Corp26,015,003 shares · 2.03% · Reported 2026-03-31
  4. Massachusetts Financial Services Company21,437,599 shares · 1.68% · Reported 2026-03-31
  5. Morgan Stanley - Brokerage Accounts20,717,029 shares · 1.62% · Reported 2026-03-31
  6. Deutsche Bank AG19,002,414 shares · 1.49% · Reported 2026-03-31
  7. iShares Core S&P 500 ETF17,096,658 shares · 1.34% · Reported 2026-08-31
  8. Amvescap Plc.16,786,998 shares · 1.31% · Reported 2026-03-31

Earnings, Profitability & Valuation

Earnings & Revenue

Revenue, Net Income, and Free Cash Flow

Revenue, Net Income, and Free Cash FlowAnnual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.-222M9.76B19.73B29.71B39.69BApr 2017Jul 2019Oct 2021Jan 2024Apr 2026
  • Revenue
  • Free cash flow
  • Net income
Annual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.

Valuation

Historical P/E Ratio

Historical P/E RatioPublished valuation snapshots. Trailing four-quarter earnings where available; annual earnings otherwise. Non-positive earnings are omitted. Values in times earnings.20.6823.8326.9830.1333.28Apr 2022Apr 2023Apr 2024Apr 2025Apr 2026
  • Published P/E
Published valuation snapshots. Trailing four-quarter earnings where available; annual earnings otherwise. Non-positive earnings are omitted. Values in times earnings.

Profitability & Margins

Profitability Margins

Profitability MarginsAnnual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.4.422.340.258.176.01Apr 2017Jul 2019Oct 2021Jan 2024Apr 2026
  • Gross margin
  • Operating margin
  • Net margin
  • Free cash flow margin
Annual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.

Medtronic (MDT) Financials, Profile & Valuation | iPulse AI